Page last updated: 2024-11-07

prednisone and Glycogen Storage Disease

prednisone has been researched along with Glycogen Storage Disease in 1 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Glycogen Storage Disease: A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement.

Research Excerpts

ExcerptRelevanceReference
"Treatment with prednisone, carnitine, vitamins and food containing carnitine rich is very effective."1.31[Studies of the clinicopathological changes of eight patients with lipid storage myopathy]. ( Wang, C; Xu, X; Yin, J, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, C1
Yin, J1
Xu, X1

Other Studies

1 other study available for prednisone and Glycogen Storage Disease

ArticleYear
[Studies of the clinicopathological changes of eight patients with lipid storage myopathy].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2001, Volume: 30, Issue:1

    Topics: Adolescent; Adult; Cytochrome-c Oxidase Deficiency; Female; Glycogen Storage Disease; Humans; Lipido

2001